Literature DB >> 24833665

A MicroRNA cluster at 14q32 drives aggressive lung adenocarcinoma.

Ernest Nadal1, Jinjie Zhong2, Jules Lin3, Rishindra M Reddy3, Nithya Ramnath3, Mark B Orringer3, Andrew C Chang3, David G Beer1, Guoan Chen1.   

Abstract

PURPOSE: To determine whether different subtypes of lung adenocarcinoma (AC) have distinct microRNA (miRNA) expression profiles, and to identify miRNAs associated with aggressive subgroups of resected lung AC. EXPERIMENTAL
DESIGN: miRNA expression profile analysis was performed in 91 resected lung AC and 10 matched nonmalignant lung tissues using a PCR-based array. An independent cohort of 60 lung ACs was used for validating by quantitative PCR the top 3 prognostic miRNAs. Gene-expression data from 51 miRNA profiled tumors was used for determining transcript-specific miRNA correlations and gene-enrichment pathway analysis.
RESULTS: Unsupervised hierarchical clustering of 356 miRNAs identified 3 major clusters of lung AC correlated with stage (P = 0.023), tumor differentiation (P < 0.003), and IASLC histologic subtype of lung AC (P < 0.005). Patients classified in cluster 3 had worse survival as compared with the other clusters. Eleven of 22 miRNAs associated with poor survival were encoded in a large miRNA cluster at 14q32. The top 3 prognostic 14q32 miRNAs (miR-411, miR-370, and miR-376a) were validated in an independent cohort of 60 lung AC. A significant association with cell migration and cell adhesion was found by integrating gene-expression data with miR-411, miR-370, and miR-376a expression. miR-411 knockdown significantly reduced cell migration in lung AC cell lines and this miRNA was overexpressed in tumors from patients who relapsed systemically.
CONCLUSIONS: Different morphologic subtypes of lung AC have distinct miRNA expression profiles, and 3 miRNAs encoded at 14q32 (miR-411, miR-370, and miR-376a) were associated with poor survival after lung AC resection. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24833665     DOI: 10.1158/1078-0432.CCR-13-3348

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  42 in total

1.  MicroRNA-154 inhibits growth and invasion of breast cancer cells through targeting E2F5.

Authors:  Hui Xu; Dan Fei; Shan Zong; Zhimin Fan
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

2.  MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3.

Authors:  Weihua Chang; Menggang Liu; Jianhua Xu; Hangwei Fu; Bo Zhou; Tao Yuan; Ping Chen
Journal:  Tumour Biol       Date:  2016-09-16

3.  Molecular and Functional Networks Linked to Sarcopenia Prevention by Caloric Restriction in Rhesus Monkeys.

Authors:  Timothy W Rhoads; Josef P Clark; Grace E Gustafson; Karl N Miller; Matthew W Conklin; Tyler M DeMuth; Mark E Berres; Kevin W Eliceiri; Laura K Vaughan; Christine W Lary; T Mark Beasley; Ricki J Colman; Rozalyn M Anderson
Journal:  Cell Syst       Date:  2020-01-22       Impact factor: 10.304

4.  MicroRNAs are key regulators of hepatocellular carcinoma (HCC) cell dissemination-what we learned from microRNA-494.

Authors:  Margarita González-Vallinas; Kai Breuhahn
Journal:  Hepatobiliary Surg Nutr       Date:  2016-08       Impact factor: 7.293

5.  MiR-22-3p suppresses cell growth via MET/STAT3 signaling in lung cancer.

Authors:  Xia Yang; Wenmei Su; Yu Li; Zhiqing Zhou; Yi Zhou; Hu Shan; Xiaoling Han; Ming Zhang; Qiuhong Zhang; Ying Bai; Chunfang Guo; Shuanying Yang; David G Beer; Guoan Chen
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

6.  Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas.

Authors:  Kavneet Kaur; Aanchal Kakkar; Anupam Kumar; Suvendu Purkait; Supriya Mallick; Vaishali Suri; Mehar C Sharma; Pramod K Julka; Deepak Gupta; Ashish Suri; Chitra Sarkar
Journal:  J Neurooncol       Date:  2016-08-30       Impact factor: 4.130

7.  miR-411 contributes the cell proliferation of lung cancer by targeting FOXO1.

Authors:  Zhiju Zhao; Limei Qin; Shu Li
Journal:  Tumour Biol       Date:  2015-11-17

8.  miR-15a and miR-24-1 as putative prognostic microRNA signatures for pediatric pilocytic astrocytomas and ependymomas.

Authors:  M Braoudaki; G I Lambrou; K Giannikou; S A Papadodima; A Lykoudi; K Stefanaki; G Sfakianos; A Kolialexi; F Tzortzatou-Stathopoulou; M Tzetis; S Kitsiou-Tzeli; E Kanavakis
Journal:  Tumour Biol       Date:  2016-01-26

9.  Validation of a serum 4-microRNA signature for the detection of lung cancer.

Authors:  Xia Yang; Wenmei Su; Xiuyuan Chen; Qianqian Geng; Jingyi Zhai; Hu Shan; Chunfang Guo; Zhuwen Wang; Han Fu; Hui Jiang; Jules Lin; Kiran Hari Lagisetty; Jie Zhang; Yali Li; Shuanying Yang; Pierre P Massion; David G Beer; Andrew C Chang; Nithya Ramnath; Guoan Chen
Journal:  Transl Lung Cancer Res       Date:  2019-10

10.  Loss of Selenoprotein Iodothyronine Deiodinase 3 Expression Correlates with Progression of Complete Hydatidiform Mole to Gestational Trophoblastic Neoplasia.

Authors:  Jessica D St Laurent; Lawrence H Lin; David M Owen; Izildinha Maestá; Arnold Castaneda; Kathleen T Hasselblatt; Donald P Goldstein; Neil S Horowitz; Ross S Berkowitz; Kevin M Elias
Journal:  Reprod Sci       Date:  2021-06-15       Impact factor: 2.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.